Journal of Addiction Medicine

Papers
(The H4-Index of Journal of Addiction Medicine is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Alcohol Consumption in Response to the COVID-19 Pandemic in the United States176
Opioid Use Disorder and COVID-19: Crashing of the Crises137
Innovation During COVID-19: Improving Addiction Treatment Access117
The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update106
Defining Low-threshold Buprenorphine Treatment99
Gambling During the COVID-19 Crisis – A Cause for Concern88
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report64
Opioid Policy Changes During the COVID-19 Pandemic - and Beyond62
The Relationship Between Children's Problematic Internet-related Behaviors and Psychological Distress During the Onset of the COVID-19 Pandemic: A Longitudinal Study51
Canadian Cannabis Consumption and Patterns of Congenital Anomalies: An Ecological Geospatial Analysis49
Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder44
Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl43
Recommended Use of Terminology in Addiction Medicine42
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2)38
Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study36
Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices?36
A Telemedicine Buprenorphine Clinic to Serve New York City: Initial Evaluation of the NYC Public Hospital System's Initiative to Expand Treatment Access During the COVID-19 Pandemic35
The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management34
Rejection of Patients With Opioid Use Disorder Referred for Post-acute Medical Care Before and After an Anti-discrimination Settlement in Massachusetts33
“Like Yin and Yang”: Perceptions of Methamphetamine Benefits and Consequences Among People Who Use Opioids in Rural Communities32
Impacts of the COVID-19 Shutdown on Gambling Patterns in Australia: Consideration of Problem Gambling and Psychological Distress32
The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities32
Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment: 12-Month Longitudinal Outcomes From RECOVER, an Observational Study31
Disparities in Access to Medications for Opioid Use Disorder in the Veterans Health Administration31
Adapting a Low-threshold Buprenorphine Program for Vulnerable Populations During the COVID-19 Pandemic29
Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review28
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis28
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report27
0.058367967605591